Biosite Diagnostics Inc., Eos Biotechnology, Medarex deal

Eos will use antibodies developed with BSTE’s phage-display and MEDX’s HuMAb antibody

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE